APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 64 filers reported holding APTEVO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | 0.0% | 11,296 | -4.9% | 0.00% | – |
| Q3 2019 | $7,000 | -30.0% | 11,880 | +4.4% | 0.00% | – |
| Q2 2019 | $10,000 | +900.0% | 11,380 | +724.6% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 1,380 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -88.2% | 1,380 | -59.7% | 0.00% | – |
| Q3 2018 | $17,000 | 0.0% | 3,425 | +1.3% | 0.00% | – |
| Q2 2018 | $17,000 | +240.0% | 3,380 | +144.9% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 1,380 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | +100.0% | 1,380 | -1.2% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 1,397 | +1.2% | 0.00% | – |
| Q2 2017 | $3,000 | -40.0% | 1,380 | -37.0% | 0.00% | – |
| Q1 2017 | $5,000 | -37.5% | 2,191 | -28.3% | 0.00% | – |
| Q4 2016 | $8,000 | +100.0% | 3,057 | +105.3% | 0.00% | – |
| Q3 2016 | $4,000 | – | 1,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,413,421 | $2,008,000 | 1.95% |
| Worth Venture Partners, LLC | 375,669 | $221,000 | 0.13% |
| Park West Asset Management LLC | 1,000,000 | $588,000 | 0.03% |
| ALGERT GLOBAL LLC | 74,906 | $44,000 | 0.02% |
| Sessa Capital IM, L.P. | 180,149 | $106,000 | 0.01% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $28,858,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,450,000 | $1,442,000 | 0.01% |
| Alyeska Investment Group, L.P. | 750,000 | $441,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 78,000 | $46,000 | 0.00% |
| A.R.T. Advisors, LLC | 69,934 | $41,000 | 0.00% |